genOway’s presentation at the PEGS Boston 2026

‍

Monday, May 11, 2026 | 10 am during the track: Emerging T Cell Engagers

‍

Presenter: Kader Thiam, CSO & SVP – Discovery, Preclinical Models & Services

Title: "Enhancing the Translational Relevance of TCE Efficacy and Safety in Preclinical Models"

• Outlining genO-BRGSF-HIS mice: a CD34⁺-reconstituted model with functional human lymphoid and myeloid compartments, without side effects
• Evidencing the recruitment of human immune cells to tumor microenvironment, as well as their activation status
• Highlighting the key role of myeloid compartment in the translatable assessment of biologic's safety in humanized models